ARS Pharmaceuticals, Inc. (SPRY) Gross margin
ARS Pharmaceuticals, Inc. (SPRY) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRY financial trends
SPRY RevenueSPRY Net incomeSPRY Net marginSPRY Gross profitSPRY Operating incomeSPRY Operating marginSPRY Operating cash flowSPRY Free cash flowSPRY Capital expendituresSPRY Return on equitySPRY Stock buybacksSPRY Dividends paidSPRY Total assetsSPRY Total liabilitiesSPRY Shareholders’ equitySPRY overview →